Open AccessReasoned opinion on the modification of the existing MRL for cyproconazole in poppy seed
Publication year - 2012
Publication title -
efsa journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.076
H-Index - 97
ISSN - 1831-4732
DOI - 10.2903/j.efsa.2012.2834
Subject(s) - poppy , european commission , enforcement , czech , health claims on food labels , microbiology and biotechnology , agricultural science , business , member state , food safety , member states , toxicology , environmental health , food science , european union , medicine , political science , biology , law , botany , linguistics , philosophy , economic policy
In accordance with Article 6 of Regulation (EC) No 396/2005, the Czech Republic, herewith referred to as the evaluating Member State (EMS), received an application from Syngenta Czech s.r.o to modify the existing MRL for the active substance cyproconazole in poppy seed. In order to accommodate for the intended use of cyproconazole, the EMS proposed to raise the existing MRL from the limit of quantification (0.05* mg/kg) to 0.3 mg/kg. The EMS drafted an evaluation report according to Article 8 of Regulation (EC) No 396/2005, which was submitted to the European Commission and forwarded to EFSA. According to EFSA the data are sufficient to derive a MRL proposal of 0.4 mg/kg for the proposed use on poppy seed. There is evidence that adequate analytical enforcement methods are available to control residues of cyproconazole in plant matrices with high fat content at the LOQ of 0.01 mg/kg. Based on the risk assessment results, EFSA concludes that intended use of cyproconazole on poppy seed will not result in a consumer exposure exceeding the toxicological reference values for the parent compound and therefore is unlikely to pose a public health concern.